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Mesoionic compounds were
evaluated against Leishmania
amazonensis.
 Mechanism of action focused the
activities of nitric oxide synthase and
arginase.
 All derivatives tested were able to
inhibit the parasite nitric oxide
synthase.
 None of the compounds was able to
inhibit the arginase activity of axenic
amastigotes.
 Those compounds were able to
inhibited arginase activity in
promastigotes.g r a p h i c a l a b s t r a c t
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Leishmaniasis is a spectrum of infectious diseases caused by Leishmania protozoan parasites. The pur-
pose of this study was to perform, in vitro, a comparative analysis of the activity amastigotes. Results
showed excellent efﬁcacy of all compounds against axenic amastigotes, compared to pentamidine ise-
thionate, the reference drug used. The cytotoxic effect of these mesoionic compounds of six mesoionic
compounds (three 1,3,4-thiadiazolium-2-aminide and three 1,2,3-oxadiazolium-5-olate class com-
pounds) was evaluated in mouse peritoneal macrophages using MTT assay, low toxicity (10%) for
these mammalian cells being observed. In an attempt to deﬁne a potential drug target, the activities
of nitric oxide synthase (NOS) and arginase of the parasites treated with the mesoionic derivatives
were evaluated. NOS was puriﬁed from a cell-free extract of infective promastigotes and axenic
amastigotes and all derivatives tested were able to inhibit the enzyme as monitored by the decrease
of NADPH consumption. Arginase activity from both stages of the parasite was measured using urea
production and none of the compounds inhibited the enzyme activity of axenic amastigotes. On the
R.J. Soares-Bezerra et al. / Experimental Parasitology 135 (2013) 50–54 51other hand, when tested with promastigotes, those compounds without and substituents inhibited
arginase activity.
 2013 Elsevier Inc. All rights reserved.1. Introduction
Leishmaniasis is a spectrum of diseases caused by protozoa par-
asites of the Leishmania genus which are transmitted by sandﬂies
(Singh and Sivakumar, 2004). There are over 17 species of Leish-
mania known to be infective to humans. These have been charac-
terized on the basis of biochemical and molecular differences
which provide a structure for phylogenetic analysis and improved
methods of species identiﬁcation and diagnosis (Herwaldt, 1999).
Today there are 12 million humans infected, mostly distributed
in tropical and subtropical countries. Among the 1.5 million new
cases estimated to occur annually, approximately 40% cases are
actually reported (Cupolillo et al., 2000). Depending on the causa-
tive species, infection can manifest as cutaneous leishmaniasis
(CL), mucocutaneous leishmaniasis (MCL), diffused cutaneous
leishmaniasis (DCL) and visceral leishmaniasis (VL). Leishmania
amazonensis, the species used in our study, has been found in many
regions of Brazil and is associated with all four forms of this dis-
ease, which enhances its epidemiological signiﬁcance (Barral
et al., 1991; Leon et al., 1992).
L-Arginine plays a central role in the biosynthesis of various
products, including nitric oxide (NO), urea, creatine phosphate,
proline and polyamines via the ornithine decarboxylase (ODC)
pathway. Several parasites are highly sensitive to NO and its deriv-
atives. NO in micromolar concentrations is cytotoxic for microbial
organisms and tumor cells. L-arginine is involved in the production
of both NO, mediated by the different isofoms of nitric oxide syn-
thase (NOS), and L-ornithine, mediated by arginase. Arginase
hydrolyzes L-arginine to L-ornithine and urea and favors parasite
growth. Polyamines have multiple roles in stabilizing nucleic acids
and membranes, as well as regulating cell growth and differentia-
tion (Moali et al., 1998; Vincendeau et al., 2003). The cellular pro-
duction of NO absolutely depends on the availability of arginine
because no other physiological amino acid or guanidine containing
compound can substitute it as a substrate for NOS. NO synthesis
must be accurately regulated, as NO is implicated in the patho-
physiology of parasitic diseases (Vincendeau et al., 2003). Thus,
NOS and arginase pathways have opposite biological effects
(Hrabák et al., 1994). Previous results from our laboratory reported
on the NO production by Leishmania sp. and the participation of the
NO-L. amazonensis pathway in the host/parasite interaction (Géigel
and Leon, 2003; Genestra et al., 2003a, b, c). Although macrophages
trigger their defense mechanism to neutralize the parasite, there is
evidence that the NO pathway from L. amazonensis participates in
the parasite–host interaction, and there is a correlation between
NO production and the amount of metacyclic forms in the culture
of infective forms (Temporal et al., 2005).The identiﬁcation of par-
asite factors that induce arginase, as well as signaling involving NO,
will make it possible to target the interference in the modulation
NOS/arginase pathway (Vincendeau et al., 2003). Mesoionic com-
pounds are a subclass of betaines, where the formal positive charge
is associated with the ring atoms and the formal negative charge is
associated either with ring atoms or an exocyclic atom. Mesoionic
classes have provided numerous compounds with antibacterial,
anti-inﬂammatory, antitrypanocidal and antitumor properties (da
Silva et al., 2002; Senff-Ribeiro et al., 2004; da Silva Ferreira
et al., 2008). Their potential value as biologically active substances
is mainly due to the planar aromatic character and the separated
regions with positive and negative charges. In this work, as a part
of our research program on experimental leishmaniasischemotherapy, we have tested six newly synthesized compounds
(three thiadiazolium and three oxadiazolium derivatives) to deter-
mine their effect on the proliferation and on NOS/arginase path-
ways in L. amazonensis promastigotes and axenic amastigotes as
well as their toxicity to mammalian cells.
2. Material and methods
2.1. Compounds
Mesoionic compounds 4-phenyl-5-(40-X-phenyl)-1,3,4-thia-
diazolium-2-phenylaminidechlorides (MI-H, MI-OCH3 or MI-NO2)
and 3[N-40-X-pheny]-1,2,3-oxadiazolium-5-olate (SID-H, SID-
OCH3 or SID-NO2) were synthesized (Fig. 1) and their structure
conﬁrmed by 1H-NMR, 13C-NMR and mass spectrometry as previ-
ously reported (Moretto-dos-Reis, 2008; Dunkley and Thoman,
2003). Pentamidine isethionate (FilaxisLaboratory S.A.) was used
as reference drug.
2.2. Reagents
Benzamidine, trypsin inhibitor, penicillin G, KCl, leupeptin,
L-glutamine, streptomycin sulfate, Schneider’s Insect Medium,
MgCl2, phenylmethylsulfonyl ﬂuoride (PMSF), N-1-naphtylethy-
lenediamine, phosphoric acid, polyethyleneglycol, sulfanilamide,
sucrose, TrisHCl, dithiotreitol (DTT), aprotinin, L-arginine, NADH,
NADP, NADPH, L-NAME (N.-nitro-L-Arginine methyl esther), EDTA,
ethanol, MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tetrazo-
lium bromide), DMSO, Triton X100, a-isonitrosopropienophenone,
H2SO4, H3PO4, 5,6,7,8-tetrahydrobiopterin (H4B), 20,50-ADP agarose,
RPMI and DMSO were from Sigma Chemical Co., St. Louis, MO
(USA).Glycerol, was from BioRad (USA). Fetal calf serum (FCS)
was from Gibco BRL(USA).
2.3. Parasites
Infective promastigotes of L. amazonensis (MHOM/BR/77/
LTB0016 strain), containing a high percentage (73%) of metacyclic
forms (evaluated through complement lysis assay were grown at
26 C at pH 7.2 in Schneider’s insect medium supplemented with
10% (v/v) heat-inactivated fetal calf serum (FCS). L. amazonensis
axenic amastigotes were cultured at 32 C in pH 5.5 in the same
medium, supplemented with 20% (v/v) FCS, 0.5 mM HEPES and
0.5 mM glutamine. (Cysne-Finkelstein et al., 1998).
2.4. Drug assay
The in vitro efﬁcacy of the mesoionic compounds was veriﬁed
on promastigotes and axenic amastigotes of L. amazonensis. Para-
sites, after been harvested from the medium, were counted in Neu-
bauer’s chamber and adjusted to a concentration of
4  106 parasites/mL. Mesoionic compounds were added to the
above parasite cultures for screening, using a 96-well microtitre
plate, in a concentration range of 320–0.15 lg/mL solubilized in di-
methyl sulphoxide (DMSO). Pentamidine isethionate was used as
reference drug (Canto-Cavalheiro et al., 1997). After 24 h of incuba-
tion at speciﬁc temperatures (26 C for promastigotes and 32 C for
axenic amastigotes), MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphe-
nyl-tetrazolium bromide) was added to the samples and the absor-
bance was read in a wavelength at 570 nm (MicroQuant
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Fig. 1. a) Mesoionic compounds 4-phenyl-5-(4´-X-phenyl)-1,2,3-thiadiazolium-2-phenylamine chlorides, where X=H (MI-H), OCH3 (MI-OCH3) and NO2 (MI-NO2); b)
Mesoionic compounds [N-4’-X-phenyl]-1,2,3-oxadiazolium-5-olate, where X = H (SID-H), OCH3 (SID-OCH3) and NO2 (SID-NO2).
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IC50/24 h value was calculated by the Origin version 5.0 software
(Microcal Software, Inc.) with a speciﬁc toolbox for estimating
curves and the percentage of growth inhibition was calculated
compared to the controls (parasites without drug).
2.5. Toxicity assay
The cytotoxic effect of the mesoionic compounds was expressed
as cell viability, and the assays were realized on mouse peritoneal
macrophages. The cells were isolated from peritoneal cavity of
BALB/c mouse with cold RPMI 1640 medium, supplemented
with1 mM L-glutamine, 1 M HEPES, penicillin G (105 IU-I) and
streptomycin sulfate (0.10 g L-1). The 2  106 cells/well were culti-
vated on microplate and incubated at 37 C in a humidiﬁed 5% CO2
atmosphere. After 2 h of incubation non adherent cells were re-
moved and the adhered macrophages were washed twice with
RPMI. Compounds were added to the cell culture at the respective
IC50 obtained for axenic amastigotes of L. amazonensis and incu-
bated for 24 h. After that, MTT was added and after 2 h the reaction
was interrupted with DMSO. The results were read in MicroQuant
spectrophotometer (Biotek-Instrument Inc., Winooski, VT) in a
wavelength of 570 nm (Mosmann, 1983; Mshana et al., 1998).
2.6. NOS-L. amazonensis isolation from promastigotes and axenic
amastigotes
The NOS puriﬁcation method was the same used by Basu et al.
(1997). Brieﬂy: cell-free extract was prepared from infective
promastigotes and axenic amastigotes by freeze–thawing the cell
suspension (5  109 cells/mL) 3–5 times and sonicated 5  45 s in
ice in 0.25 M sucrose containing 5 mM KCl. The contents were cen-
trifuged at 10,000g for 30 min and the supernatant was adjusted in
an antiproteolytic buffer containing 0.1 mM PMSF (phenylmethyl-
sulfonyl ﬂuoride), 0.01% (p/v) leupeptin, 0.2 mg/mL trypsin inhibi-
tor and 1 mM benzamidine to a ﬁnal volume of 5 mL. The crude
soluble extract was centrifuged at 100,000g for 60 min at 4 C
and the supernatant (1.3 mg/mL protein) was applied to a column
(8.5  1.5 cm) packet with 20,50-ADP agarose equilibrated with
10 mM Tris–HCl, pH 7.5 containing 1 mM DTT (dithiotreitol),
1 mM EDTA, 0.5 mM PMSF, 25 units/mL aprotinin and 0.5 mM
L-arginine (buffer A). The column was then washed successively
with 20 mL of buffer A plus 0.5 mM NADH. The enzyme was eluted
with 10 mL of buffer A containing 10 mM NADPH, 3 lM H4B and
10% (v/v) glycerol. The eluted material was then concentrated by
dialysis using a semipermeable membrane of polyethyleneglycol
400 (PEG400). The protein concentration (240 lg/mL) was esti-
mated spectrophotometricaly.2.7. NOS-L. amazonensis activity
The activity of NOS puriﬁed from infective promastigotes and
axenic amastigotes was determined by measuring NADPH oxida-
tion in the absorbance at 340 nm for 10 min continuously, since
this cofactor was consumed during the conversion of L-arginine
to L-citrulline by NOS. The complete enzyme reaction mixture con-
tained 50 mM potassium phosphate buffer (pH 7.4), 1 mM CaCl2,
0.1 mM NADPH, 80 lM H4B, 10 lM FAD, 10 lM FMN, 0.1 mM
L-arginine and 2 lg enzyme in a ﬁnal volume of 1 mL. Alternatively
MI-H, MI-OCH3, MI-NO2, SID-H, SID-OCH3 and SID-NO2 were used
in the reaction mixture in the following concentrations: 6.5, 12, 13,
31, 22 and 27 lM for promastigotes and 9.5, 13, 5.5, 29, 28 and
31 lM for axenic amastigotes, respectively. Pentamidine isethio-
nate was used in the reaction mixture as a reference drug using
the corresponding IC50 (0.46 lM for promastigotes and 118 lM
for axenic amastigotes (da Silva et al., 2002). The control group
contained all the components of the reaction mixture, except the
drugs, and the blank had all the components, except NADPH and
the drugs.2.8. Arginase-L. amazonensis activity
Arginase activity was evaluated from L. amazonensis promastig-
otes and axenic amastigotes treated for 24 h with the correspond-
ing IC50 of MI-H, MI-OCH3, MI-NO2,SID-H, SID-OCH3 and SID-NO2
as previously described (Corraliza et al., 1994) with somemodiﬁca-
tions. Brieﬂy, 106 cells previously washed with a solution of 0.25 M
sucrose and 5 mMKCl were added to 0.5 mL of 0.1% Triton X-100 in
an antiproteolytic buffer containing 0.1 mM phenylmethylsulfonyl
ﬂuoride, 0.01% w/v leupeptin,0.2 mg/mL trypsin inhibitor and
1 mM benzamidine in 0.25 M sucrose and 5 mM KCl. The mixture
was then stirred for 30 min at room temperature. After the cells ly-
sis, 0.5 mL of 25 mM Tris–HCl plus 5 mM of MnCl2, pH7.4 were
added and the reaction was activated for 10 min at 56 C. Arginine
hydrolysis was initiated by the addition of 25 lL of 0.5 M L-argi-
nine, pH9.7 to a 25 lL aliquot of the previously activated lysate.
Incubation was performed at 37 C for 60 min and the reaction
was stopped by the addition of 400 lL of an acid mixture contain-
ing H2SO4, H3PO4, and H2O (1:3:7). The formed urea was quantiﬁed
at 540 nm after addition of 25 lL of 9% a-isonitrosopropienophe-
none (dissolved in 100% ethanol) and heating at 100 C for
45 min. After 10 min in the dark, the optical density was deter-
mined in a spectrophotometer using 200 lL aliquots in a non-ster-
ile micro-culture plate. A calibration curve was prepared with
increasing amounts of urea in a concentration range from 1.5 to
30 lg/mL.
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Each experiment was repeated three or four times, each time in
triplicate. Signiﬁcance was determined using a non-paired t Stu-
dent test and 1-way ANOVA. Differences were considered to be sig-
niﬁcant when p < 0.05.3. Results and discussion
In this work, the effect of six mesoionic compounds on the
growth of promastigotes (late log phase) and axenic amastigotes
was evaluated and the IC50 values obtained for all compounds
tested can be observed on Table 1. After incubation for 24 h with
both forms of L. amazonensis in their respective culture conditions,
the values of 4-phenyl-5-(40-X-phenyl)-1,3,4 thiadiazolium-2-
phenylamine chlorides (MI, where X = H, OCH3 and NO2) for prom-
astigotes were 6.5, 12 and 13 lM, respectively. For axenic amastig-
otes these values were 9.5, 13 and 5.5 lM, respectively. All the
compounds were more effective against axenic amastigotes, com-
pared to Pentamidine isethionate (p > 0.05). Interestingly, MI-
NO2 was the most effective against axenic amastigotes, conﬁrming
the efﬁcacy of this compound against tumor cell lines (K562, HL60
and Daudi lymphoma [unpublished data]. Within mesoionic com-
pound series studied so far, sydnones have attained importance
due not only to their structural features and chemical properties,
but also to their biological properties. Sydnone derivatives have
been extensively studied for their biological activities, the antimi-
crobial activity of aryl sydnones has been reported (Moustafa et al.,
2004). Aryl sydnones are less toxic and more active than alkyl syd-
nones (Pilli et al., 1993). When [N-40-X-phenyl]-1,2,3-oxadiazoli-
um-5 olate (SID, where X = H, OCH3 and NO2) was tested, it was
obtained the following IC50 values for promastigotes: 31, 22 and
27 lM, respectively. For axenic amastigotes, IC50 values were 29,
28 and 31 lM, respectively. All the compounds were more effec-
tive than Pentamidine isethionate (118 lM) against axenic
amastigotes (p > 0.05). This is important, because all mesoionic
compounds tested here were more effective against amastigotes
than promastigotes. Amastigotes are the infective form for the ver-
tebrate host, and these data should encourage future studies eval-
uating the effect on intracellular amastigotes in vitro and
inexperimental in vivo model. Cytotoxicity assays using three thia-
diazolium and three oxadiazolium derivatives incubated with
murine macrophages for 24 h showed promising results (Table 1).
For the 4-phenyl-5-(40-X-phenyl)-1,3,4-thiadiazolium-2-phenyla-
mine chloride series, a very low cytotoxicity (<10%) was observed
when compared to Pentamidine isethionate (49%, p > 0.05). With
the [N-40-X-phenyl]-1,2,3 oxadiazolium-5-olate series, both the
SID-H and SID-NO2 showed <10% toxicity, while the methoxy
derivative (SID-OCH3) showed about 13% cytotoxicity. TheseTable 1
IC50 (compound concentration required to kill 50% + SD of the parasite) of MI-H, MI-
OCH3, MI-NO2, SID-H, SID-OCH3 and SID-NO2 against L. amazonensis. Toxicity to
mouse macrophage is also presented as percentage. All assays were performed three
times, in triplicate.
Compound IC50
(lM)
Cytotoxicity (%)
Promastigotes Axenic
amastigotes
Mouse peritoneal
macrophage
MI MI-H 6.5 ± 0.02 9.5 ± 0.03 4.0 ± 0.03
MI-OCH3 12 ± 0.02 13 ± 0.01 7.5 ± 0.03
MI-NO2 13 ± 0.02 5.5 ± 0.001 8.0 ± 0.01
SID SID-H 31 ± 0.03 29 ± 0.01 9.6 ± 0.01
SID-OCH3 22 ± 0.02 28 ± 0.02 13 ± 0.02
SID-NO2 27 ± 0.03 31 ± 0.02 6.7 ± 0.06
Pentamidinea 0.46 ± 0.05 118 ± 5.81 49.0 ± 0.05
a Reference drug.results are important for future experiments because they demon-
strate high antiparasite efﬁcacy and low mammalian cell toxicity,
which is a WHO (1990) recommendation for leishmaniasis treat-
ment. The effect of thiadiazolium and oxadiazolium derivatives
on NADPH consumption by the NOS puriﬁed from L. amazonensis
showed interesting data. All compounds had a higher inhibitory
capacity on assays with NOS puriﬁed from axenic amastigotes,
when compared with promastigotes (p > 0.05). MI-H, MI-OCH3
and MI-NO2, respectively inhibit about 11%, 21% and 28% of the
NADPH consumption by NOS from promastigotes. On the other
hand, these values are 35%, 23% and 41% for NOS puriﬁed from axe-
nic amastigotes incubated with thiadiazolium derivatives. The
presence of the NO2 substituent into mesoionic derivative showed
higher inhibitory capacity, especially on an enzymatic system
involving NO biosynthesis by the parasite, in vitro. This was con-
ﬁrmed when SID-H, SID-OCH3 and SID-NO2 (29%, 27% and 47% of
inhibition of NADPH consumption from NOS promastigotes com-
pared to 36%, 36% and 63% from NOS-axenic amastigotes respec-
tively) were assayed. In all the experiments, L-NAME, a speciﬁc
inhibitor of NOS was used, demonstrating 100% of inhibition
(p < 0.05). In a recent study by our group, it was shown that Pent-
amidine isethionate was able to inhibit about 15% of NADPH con-
sumption by NOS puriﬁed from parasite (Soares-Bezerra et al.,
2008). None of the investigated compounds was able to inhibit
arginase activity of axenic amastigotes. When tested with prom-
astigotes, only the compounds without substituents (MI-H and
SID-H) inhibited arginase activity, but the best result was shown
with MI-H (p < 0.05). In a recent evaluation, it was also veriﬁed that
4-phenyl 5-(cinnamoyl)-1,3,4-thiadiazolium chloride mesoionic
derivatives were unable to decrease arginase activity of L. amazon-
ensis (Soares-Bezerra et al., 2008). The results obtained in this work
show that the mesoionic thiadiazolium derivatives MI-H and MI-
NO2 possess the best activity proﬁle, and may be prototypes for
use in the development of a new chemotherapeutic agent with
high efﬁcacy.
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